Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Olukemi A. Adekanmbi"'
Autor:
Rita O. Oladele, Iriagbonse I. Osaigbovo, Alani S. Akanmu, Olukemi A. Adekanmbi, Bassey E. Ekeng, Yahaya Mohammed, Mary A. Alex-Wele, Mark O. Okolo, Stephen T. Ayanbeku, Uchechukwu S. Unigwe, Iorhen E. Akase, Alali Dan-Jumbo, Dennis Isralski, David W. Denning, Alessandro C. Pasqualotto, Tom Chiller
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 11, Pp 2261-2269 (2022)
We sought to determine the prevalence of probable disseminated histoplasmosis among advanced HIV disease (AHD) patients in Nigeria. We conducted a cross-sectional study in 10 sites across 5 of 6 geopolitical zones in Nigeria. We identified patients w
Externí odkaz:
https://doaj.org/article/660e001a622548b49147ee22ac7d57a1
Autor:
Olukemi Osinusi-Adekanmbi MD, MPH, Kristen Stafford MPH, Adiba Ukpaka MBBS, Donald Salami MSc, Samuel Ajayi MBBS, Nicaise Ndembi PhD, Alash’le Abimiku PhD, Chidi Nwizu MD, Bruce Gilliam MD, Robert Redfield MD, Anthony Amoroso MD
Publikováno v:
Journal of the International Association of Providers of AIDS Care, Vol 13 (2014)
There is limited information on efficacy and durability of second-line antiretroviral therapy (2NL) beyond 12 months in resource-limited settings. A total of 73 patients were enrolled into a prospective 2NL observational cohort in Nigeria. Second-lin
Externí odkaz:
https://doaj.org/article/b0070c8fd6364df39b3ed493558d5b1c
Autor:
Adiba Ukpaka, Donald Salami, Kristen A Stafford, Anthony Amoroso, Chidi Nwizu, Nicaise Ndembi, Alash'le Abimiku, Robert R. Redfield, Bruce L. Gilliam, Samuel Ajayi, Olukemi Osinusi-Adekanmbi
Publikováno v:
Journal of the International Association of Providers of AIDS Care, Vol 13 (2014)
There is limited information on efficacy and durability of second-line antiretroviral therapy (2NL) beyond 12 months in resource-limited settings. A total of 73 patients were enrolled into a prospective 2NL observational cohort in Nigeria. Second-lin